{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:22:42Z","timestamp":1791573762942,"version":"4.3.4"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early diagnosis of encephalitis involves identifying signs of neuroinflammation, including cerebrospinal fluid (CSF) pleocytosis. However, an absence of CSF pleocytosis in encephalitis has been described, most notably in autoimmune encephalitis. We examined clinical characteristics and outcomes associated with the absence or presence of CSF white blood cell pleocytosis (\u22655 cells\/\u00b5L), to inform timely diagnosis and management of encephalitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study compares initial CSF profiles in 597 adult patients with all-cause encephalitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 597 patients, 446 (74.7%) had CSF pleocytosis while 151 (25.3%) did not. CSF pleocytosis occurred more commonly in infectious cases (200\/446, 44.8%), along with 59 (13.2%) autoimmune cases, comprised chiefly of anti\u2013N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis (37\/59, 62.7%). Notably, the group without pleocytosis comprised similar proportions of infectious (47\/151, 31.1%) and autoimmune (38\/151, 25.92%; P &amp;gt; .05) encephalitis. Among those with infectious encephalitis, 47\/247 (19%) had an absence of pleocytosis, including 18\/76 (23.7%) with HSV-1 encephalitis. The absence of pleocytosis was associated with a decreased rate of acyclovir administration (47.7% in patients without pleocytosis vs 71.1% in patients with pleocytosis; P &amp;lt; .001). Despite pleocytosis being associated with some measures of clinical severity at admission such as a Full Outline of UnResponsiveness (FOUR) score \u226414, it was not associated with mortality or prolonged hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CSF pleocytosis is an important criterion for encephalitis diagnosis, but 25.3% of patients with all-cause encephalitis and 23.7% of those with HSV-1 encephalitis exhibit an absence of pleocytosis on initial LP. Acyclovir initiation should not be delayed in the absence of pleocytosis in patients with suspected encephalitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciae391","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T20:21:23Z","timestamp":1722543683000},"page":"179-187","source":"Crossref","is-referenced-by-count":35,"title":["Absence of Cerebrospinal Fluid Pleocytosis in Encephalitis"],"prefix":"10.1093","volume":"81","author":[{"given":"Ralph","family":"Habis","sequence":"first","affiliation":[{"name":"Johns Hopkins Encephalitis Center, Department of Neurology, Johns Hopkins University, School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kolchinski","sequence":"additional","affiliation":[{"name":"Johns Hopkins Encephalitis Center, Department of Neurology, Johns Hopkins University, School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley N","family":"Heck","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Infectious Disease, McGovern Medical School, UTHealth Science Center , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paris","family":"Bean","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Infectious Disease, McGovern Medical School, UTHealth Science Center , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C","family":"Probasco","sequence":"additional","affiliation":[{"name":"Johns Hopkins Encephalitis Center, Department of Neurology, Johns Hopkins University, School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Hasbun","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Infectious Disease, McGovern Medical School, UTHealth Science Center , Houston, Texas ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9335-7361","authenticated-orcid":false,"given":"Arun","family":"Venkatesan","sequence":"additional","affiliation":[{"name":"Johns Hopkins Encephalitis Center, Department of Neurology, Johns Hopkins University, School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,3]]},"reference":[{"key":"2025080104321166800_ciae391-B1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/589747","article-title":"The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"47","author":"Tunkel","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2025080104321166800_ciae391-B2","doi-asserted-by":"crossref","first-page":"890656","DOI":"10.3389\/fimmu.2022.890656","article-title":"Clinical features, treatment, and prognostic factors in neuronal surface antibody-mediated severe autoimmune encephalitis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"2025080104321166800_ciae391-B3","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1093\/cid\/ciad306","article-title":"State of the art: acute encephalitis","volume":"77","author":"Bloch","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025080104321166800_ciae391-B4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2025080104321166800_ciae391-B5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","article-title":"Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management","volume":"92","author":"Abboud","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025080104321166800_ciae391-B6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the International Encephalitis Consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2025080104321166800_ciae391-B7","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"2025080104321166800_ciae391-B8","doi-asserted-by":"crossref","first-page":"e104169","DOI":"10.1371\/journal.pone.0104169","article-title":"Encephalitis hospitalization rates and inpatient mortality in the United States, 2000\u20132010","volume":"9","author":"George","year":"2014","journal-title":"PLoS One"},{"key":"2025080104321166800_ciae391-B9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"2025080104321166800_ciae391-B10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/dmp.2010.40","article-title":"A modified sequential organ failure assessment score for critical care triage","volume":"4","author":"Grissom","year":"2010","journal-title":"Disaster Med Public Health Prep"},{"key":"2025080104321166800_ciae391-B11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.4103\/lungindia.lungindia_106_17","article-title":"Correlation between the levels of SpO2 and PaO2","volume":"34","author":"Madan","year":"2017","journal-title":"Lung India"},{"key":"2025080104321166800_ciae391-B12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ana.20611","article-title":"Validation of a new coma scale: the FOUR score","volume":"58","author":"Wijdicks","year":"2005","journal-title":"Ann Neurol"},{"key":"2025080104321166800_ciae391-B13","doi-asserted-by":"crossref","first-page":"e1294","DOI":"10.1093\/cid\/ciac711","article-title":"Development and validation of a risk score to differentiate viral and autoimmune encephalitis in adults","volume":"76","author":"Granillo","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2025080104321166800_ciae391-B14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/QCO.0000000000000175","article-title":"Acute encephalitis in the immunocompromised individual","volume":"28","author":"Saylor","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"2025080104321166800_ciae391-B15","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1212\/WNL.0b013e3182752ceb","article-title":"Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised","volume":"79","author":"Tan","year":"2012","journal-title":"Neurology"},{"key":"2025080104321166800_ciae391-B16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/CCM.0b013e3182374a34","article-title":"Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid","volume":"40","author":"Jakob","year":"2012","journal-title":"Crit Care Med"},{"key":"2025080104321166800_ciae391-B17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13104-016-1922-9","article-title":"Normocellular CSF in herpes simplex encephalitis","volume":"9","author":"Saraya","year":"2016","journal-title":"BMC Res Notes"},{"key":"2025080104321166800_ciae391-B18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jcv.2014.03.010","article-title":"Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients","volume":"60","author":"Sili","year":"2014","journal-title":"J Clin Virol"},{"key":"2025080104321166800_ciae391-B19","doi-asserted-by":"crossref","first-page":"e1086","DOI":"10.1212\/NXI.0000000000001086","article-title":"CSF findings in acute NMDAR and LGI1 antibody\u2013associated autoimmune encephalitis","volume":"8","author":"D\u00fcrr","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025080104321166800_ciae391-B20","doi-asserted-by":"crossref","first-page":"104996","DOI":"10.1016\/j.msard.2023.104996","article-title":"Cerebrospinal fluid indices as predictors of treatment response in autoimmune encephalitis","volume":"79","author":"Popova","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"2025080104321166800_ciae391-B21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/341405","article-title":"Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study","volume":"35","author":"Raschilas","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2025080104321166800_ciae391-B22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00415-015-7960-8","article-title":"Predictors of outcome in HSV encephalitis","volume":"263","author":"Singh","year":"2016","journal-title":"J Neurol"},{"key":"2025080104321166800_ciae391-B23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1469-0691.2009.02735.x","article-title":"Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis","volume":"15","author":"Poissy","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"2025080104321166800_ciae391-B24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/0004-282x20170179","article-title":"Non-inflammatory cerebrospinal fluid delays the diagnosis and start of immunotherapy in anti-NMDAR encephalitis","volume":"76","author":"Espinola-Nadurille","year":"2018","journal-title":"Arq Neuropsiquiatr"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae391\/58862705\/ciae391.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/1\/179\/58862705\/ciae391.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/81\/1\/179\/58862705\/ciae391.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T08:32:47Z","timestamp":1754037167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/81\/1\/179\/7726814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,8,3]]},"published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae391","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,15]]},"published":{"date-parts":[[2024,8,3]]}}}